Education
About Us
Working with TipRanks
Follow Us
Cibus (CBUS)
NASDAQ:CBUS
CBUS Stock Chart & Stats
$1.22
-$0.23(-7.99%)
At close: 4:00 PM EST
$1.22
-$0.23(-7.99%)
Day’s Range― - ―
52-Week Range$1.09 - $4.96
Previous CloseN/A
Volume64.89K
Average Volume (3M)600.30K
Market Cap
$74.33M
Enterprise Value$275.23M
Total Cash (Recent Filing)$23.89M
Total Debt (Recent Filing)$33.95M
Price to Earnings (P/E)―
Beta3.15
Next Earnings
Mar 19, 2026EPS Estimate
-0.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding52,540,527
10 Day Avg. Volume1,378,741
30 Day Avg. Volume600,304
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.70
Price to Sales (P/S)15.15
P/FCF Ratio-1.10
Enterprise Value/Market Cap3.70
Enterprise Value/Revenue72.54
Enterprise Value/Gross Profit86.58
Enterprise Value/Ebitda-3.16
Forecast
1Y Price Target
$20.00Price Target Upside1539.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Commercialization And Revenue GrowthManagement expects the commercialization of Cibus' sustainable ingredients and biofragrance products to generate significant revenues, with expectations of material expansion in the future.
Cost Reduction And Financial EfficiencyThe company’s cost-cutting and streamlining initiative announced is now reflecting in the company’s financials with 3Q25 operating expenses coming in 15% lower sequentially.
Regulatory Advancements And Market AccessThe UK government’s implementation of a framework for Precision Bred Organisms (PBOs) opens up opportunities to find partners for the company’s pipeline traits and programs.
Bears Say
Financial PerformanceCibus announced a quarterly net loss, highlighting ongoing financial challenges despite improvements.
Cibus News
CBUS FAQ
What was Cibus’s price range in the past 12 months?
Cibus lowest stock price was $1.09 and its highest was $4.96 in the past 12 months.
What is Cibus’s market cap?
Cibus’s market cap is $74.33M.
When is Cibus’s upcoming earnings report date?
Cibus’s upcoming earnings report date is Mar 19, 2026 which is in 123 days.
How were Cibus’s earnings last quarter?
Cibus released its earnings results on Nov 13, 2025. The company reported -$0.44 earnings per share for the quarter, missing the consensus estimate of -$0.438 by -$0.002.
Is Cibus overvalued?
According to Wall Street analysts Cibus’s price is currently Undervalued.
Does Cibus pay dividends?
Cibus does not currently pay dividends.
What is Cibus’s EPS estimate?
Cibus’s EPS estimate is -0.45.
How many shares outstanding does Cibus have?
Cibus has 52,540,527 shares outstanding.
What happened to Cibus’s price movement after its last earnings report?
Cibus reported an EPS of -$0.44 in its last earnings report, missing expectations of -$0.438. Following the earnings report the stock price went down -2.4%.
Which hedge fund is a major shareholder of Cibus?
Currently, no hedge funds are holding shares in CBUS
Cibus Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$20.00 (1539.34% Upside)
$20.00 (1539.34% Upside)
Hedge Fund Trend
Decreased
By 22.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.6%
Last 30 Days ▲ 10.1%
Last 30 Days ▲ 10.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-53.76%
12-Months-Change
Fundamentals
Return on Equity
-149.99%
Trailing 12-Months
Asset Growth
-37.44%
Trailing 12-Months
Company Description
Cibus
Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.
CBUS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in commercialization, particularly in rice herbicide tolerance traits and biofragrance products, alongside notable regulatory advances. However, challenges include a revenue decline and cash runway concerns, with some regulatory delays in the EU. Overall, the call reflects a cautiously optimistic outlook.View all CBUS earnings summariesCBUS Stock 12 Month Forecast
Average Price Target
$20.00
▲(1539.34% Upside)
Technical Analysis
CervoMed
―
X4 Pharmaceuticals
―
ABVC BioPharma
―
Repare Therapeutics
―
OKYO Pharma Limited Sponsored ADR
―
Ownership Overview
32.65% Insiders
9.38% Mutual Funds
3.33% Other Institutional Investors
53.02% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---